239 related articles for article (PubMed ID: 12798573)
1. Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes.
Ammann P; Maggiorini M; Bertel O; Haenseler E; Joller-Jemelka HI; Oechslin E; Minder EI; Rickli H; Fehr T
J Am Coll Cardiol; 2003 Jun; 41(11):2004-9. PubMed ID: 12798573
[TBL] [Abstract][Full Text] [Related]
2. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome.
Casey LC; Balk RA; Bone RC
Ann Intern Med; 1993 Oct; 119(8):771-8. PubMed ID: 8379598
[TBL] [Abstract][Full Text] [Related]
3. Cardiac Troponin Measurement in the Critically Ill: Potential for Guiding Clinical Management.
Poe S; Vandivier-Pletsch RH; Clay M; Wong HR; Haynes E; Rothenberg FG
J Investig Med; 2015 Dec; 63(8):905-15. PubMed ID: 26425879
[TBL] [Abstract][Full Text] [Related]
4. Sepsis-associated myocardial dysfunction: diagnostic and prognostic impact of cardiac troponins and natriuretic peptides.
Maeder M; Fehr T; Rickli H; Ammann P
Chest; 2006 May; 129(5):1349-66. PubMed ID: 16685029
[TBL] [Abstract][Full Text] [Related]
5. Cardiac troponin I does not independently predict mortality in critically ill patients with severe sepsis.
Tiruvoipati R; Sultana N; Lewis D
Emerg Med Australas; 2012 Apr; 24(2):151-8. PubMed ID: 22487664
[TBL] [Abstract][Full Text] [Related]
6. Myocardial Dysfunction in Severe Sepsis and Septic Shock: No Correlation With Inflammatory Cytokines in Real-life Clinical Setting.
Landesberg G; Levin PD; Gilon D; Goodman S; Georgieva M; Weissman C; Jaffe AS; Sprung CL; Barak V
Chest; 2015 Jul; 148(1):93-102. PubMed ID: 25591166
[TBL] [Abstract][Full Text] [Related]
7. Cardiac troponin I elevation in hospitalized patients without acute coronary syndromes.
Blich M; Sebbag A; Attias J; Aronson D; Markiewicz W
Am J Cardiol; 2008 May; 101(10):1384-8. PubMed ID: 18471446
[TBL] [Abstract][Full Text] [Related]
8. Treatment modalities of non-ST-elevation acute coronary syndromes in the real world. Results of the prospective R.OS.A.I.-2 registry.
Registro Osservazionale Angina Instabile Investigators
Ital Heart J; 2003 Nov; 4(11):782-90. PubMed ID: 14699708
[TBL] [Abstract][Full Text] [Related]
9. Characteristics and in-hospital outcome of patients with no ST-segment elevation acute coronary syndrome and no obstructive coronary artery disease in the era of high-sensitivity troponins.
Lanza GA; Melita V; Mencarelli E; De Vita A; Bisignani A; Manfredonia L; Covino M; Crea F
J Cardiovasc Med (Hagerstown); 2019 Apr; 20(4):210-214. PubMed ID: 30720634
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular risk factors profile in patients with acute coronary syndrome with particular reference to left ventricular ejection fraction.
Khaled S; Matahen R
Indian Heart J; 2018; 70(1):45-49. PubMed ID: 29455787
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of Interleukin-1 receptor antagonist in patients with documented coronary artery disease.
Schofer N; Ludwig S; Rübsamen N; Schnabel R; Lackner KJ; Ruprecht HJ; Bickel C; Landmesser U; Blankenberg S; Zeller T
Int J Cardiol; 2018 Apr; 257():24-29. PubMed ID: 29395365
[TBL] [Abstract][Full Text] [Related]
12. Cardiac troponin elevations among critically ill patients.
Gunnewiek JM; Van Der Hoeven JG
Curr Opin Crit Care; 2004 Oct; 10(5):342-6. PubMed ID: 15385749
[TBL] [Abstract][Full Text] [Related]
13. Cardiac troponin: a new serum marker of myocardial injury in sepsis.
Fernandes CJ; Akamine N; Knobel E
Intensive Care Med; 1999 Oct; 25(10):1165-8. PubMed ID: 10551977
[TBL] [Abstract][Full Text] [Related]
14. Interaction of impaired coronary flow reserve and cardiomyocyte injury on adverse cardiovascular outcomes in patients without overt coronary artery disease.
Taqueti VR; Everett BM; Murthy VL; Gaber M; Foster CR; Hainer J; Blankstein R; Dorbala S; Di Carli MF
Circulation; 2015 Feb; 131(6):528-35. PubMed ID: 25480813
[TBL] [Abstract][Full Text] [Related]
15. Persistent preload defect in severe sepsis despite fluid loading: A longitudinal echocardiographic study in patients with septic shock.
Jardin F; Fourme T; Page B; Loubières Y; Vieillard-Baron A; Beauchet A; Bourdarias JP
Chest; 1999 Nov; 116(5):1354-9. PubMed ID: 10559099
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of initial elevation in cardiac troponin I level in critically ill patients without acute coronary syndrome.
Liu M; Shehu M; Herrold E; Cohen H
Crit Care Nurse; 2015 Apr; 35(2):e1-10. PubMed ID: 25997205
[TBL] [Abstract][Full Text] [Related]
17. Troponin elevation in other conditions than acute coronary syndromes.
Masri W; Le Guillou E; Hamdi E; Ghazal K; Lebigot E; Cosson C; Cynober FB; Therond P
Ann Biol Clin (Paris); 2017 Aug; 75(4):411-419. PubMed ID: 28751286
[TBL] [Abstract][Full Text] [Related]
18. C-reactive protein in patients with acute coronary syndrome: correlation with diagnosis, myocardial damage, ejection fraction and angiographic findings.
Brunetti ND; Troccoli R; Correale M; Pellegrino PL; Di Biase M
Int J Cardiol; 2006 May; 109(2):248-56. PubMed ID: 16055214
[TBL] [Abstract][Full Text] [Related]
19. The meaning of elevated troponin I levels: not always acute coronary syndromes.
Harvell B; Henrie N; Ernst AA; Weiss SJ; Oglesbee S; Sarangarm D; Hernandez L
Am J Emerg Med; 2016 Feb; 34(2):145-8. PubMed ID: 26508391
[TBL] [Abstract][Full Text] [Related]
20. Suspected ACS Patients Presenting With Myocardial Damage or a Type 2 Myocardial Infarction Have a Similar Late Mortality to Patients With a Type 1 Myocardial Infarction: A Report From the Australian and New Zealand 2012 SNAPSHOT ACS Study.
Etaher A; Chew D; Redfern J; Briffa T; Ellis C; Hammett C; Lefkovits J; Elliott J; Cullen L; Brieger D; French JK
Heart Lung Circ; 2017 Oct; 26(10):1051-1058. PubMed ID: 28139353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
